相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
F. Fatoye et al.
BMJ OPEN (2019)
A systematic review of factors affecting medication adherence among patients with osteoporosis
C. T. Yeam et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up
M. Belhassen et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States
R. T. Burge et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years
A. Modi et al.
OSTEOPOROSIS INTERNATIONAL (2017)
One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study
C. Reyes et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy
S. Migliaccio et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Cessation rate of anti-osteoporosis treatments and risk factors in Spanish primary care settings: a population-based cohort analysis
Elisa Martin-Merino et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
T. Petranova et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
Emily Durden et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis inGermany, Austria, Greece, and Belgium
A. Fahrleitner-Pammer et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population
Allison Keshishian et al.
Journal of Managed Care & Specialty Pharmacy (2017)
A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary
Peter Lakatos et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Real-world clinical and economic outcomes for daily teriparatide patients in Japan
Russel Burge et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2016)
Compliance, Persistence, and Preferences Regarding Osteoporosis Treatment During Active Therapy or Drug Holiday
Alona Eliasaf et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
P. Hadji et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database
D. -C. Chan et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Persistence with denosumab and zoledronic acid among older women: a population-based cohort study
Eric Tremblay et al.
ARCHIVES OF OSTEOPOROSIS (2016)
Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study
C. Carbonell-Abella et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Adherence to denosumab in the treatment of osteoporosis and its utilization in the Czech Republic
Leos Fuksa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy
Ankita Modi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
P. Hadji et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
M. M. Bonafede et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
L. Karlsson et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort study
Anne-Luise Thorsteinsson et al.
ARCHIVES OF OSTEOPOROSIS (2015)
Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States
Lung-I Cheng et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2015)
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Therapeutic adherence to osteoporosis treatment
Sona Tomkova et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: Results from the European Forsteo Observational Study
Gerald Rajzbaum et al.
JOINT BONE SPINE (2014)
Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider
I. Kyvernitakis et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
Leslie Hazel-Fernandez et al.
BMC MUSCULOSKELETAL DISORDERS (2013)
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures
Anders Oden et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
The bone evaluation study (BEST): patient care and persistence to treatment of osteoporosis in Germany
Peyman Hadji et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Non-adherence to anti-osteoporotic medications in Taiwan: physician specialty makes a difference
Shan-Fu Yu et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Meta-analysis of prevalence
Jan J. Barendregt et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2013)
Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan
Yihua Xu et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2013)
Anti-osteoporotic therapy in Denmark-predictors and demographics of poor refill compliance and poor persistence
C. Hansen et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients
Y. Zhao et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: medical management, epidemiology and economic burden
E. Hernlund et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women
Akhila Balasubramanian et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2013)
Persistence and compliance of medications used in the treatment of osteoporosis - analysis using a large scale, representative, longitudinal German database
Volker Ziller et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Adherence to treatment of primary osteoporosis and its association to fractures-the Swedish Adherence Register Analysis (SARA)
E. Landfeldt et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Adherence with intravenous zoledronate and intravenous ibandronate in the united states medicare population
Jeffrey R. Curtis et al.
ARTHRITIS CARE & RESEARCH (2012)
Comparative Performance of Private and Public Healthcare Systems in Low- and Middle-Income Countries: A Systematic Review
Sanjay Basu et al.
PLOS MEDICINE (2012)
Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone mass
Debora Castro Gomes et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance
S. A. Foster et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Partial adherence: a new perspective on health economic assessment in osteoporosis
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
I. Imaz et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users
Jeffrey R. Curtis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates
Colleen A. McHorney et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Telephone Counseling to improve osteoporosis treatment adherence: An effectiveness study in community practice settings
Paul F. Cook et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2007)
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
J. A. Cramer et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Persistence with teriparatide in patients with osteoporosis: the UK experience
N. K. Arden et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Improving compliance and persistence with bisphosphonate therapy for osteoporosis
RD Emkey et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Physician-patient relationship and medication compliance: A primary care investigation
N Kerse et al.
ANNALS OF FAMILY MEDICINE (2004)
The concordance of self-report with other measures of medication adherence - A summary of the literature
MC Garber et al.
MEDICAL CARE (2004)
分享论文
